Know what you're actually underwriting.
SCI is independent structural underwriting infrastructure that converts fragmented company evidence into a monitorable investment thesis: what is proven, what is assumed, what constrains value creation, what could change the outcome, and what would break the thesis.
SCI does not tell you whether to invest. It tells you what must be true for the investment thesis to hold.
The problem is not a lack of information.
Investment decisions increasingly have more data, more analysis, and more AI-generated commentary. The problem is determining what that information actually means for the investment thesis.
Presentations describe the opportunity. SCI structures the bet.
A pitch deck can explain why a company should win. Financial statements can describe historical performance. Customer references can establish utility. Product telemetry can establish usage.
None of those artifacts, individually, tells an investment committee what the company is structurally dependent upon—or what evidence would invalidate the investment thesis.
Conventional diligence
Is the market large? Is the team strong? Is the product good? What is the TAM? What is the growth rate?
SCI underwriting
What is structurally true? What prevents compounding? What must become true? What breaks the thesis? What should be monitored after capital is deployed?
SCI produces underwriting objects— not another report.
The output is a structured representation of the investment thesis that can be validated before deployment and monitored after deployment.
Investment Thesis
What the company is structurally becoming and why that trajectory could create value.
Binding Constraint
The structural condition currently preventing the business from compounding.
Structural Catalyst
The evidence or event capable of materially changing the investment outcome.
Durability Source
The mechanism that could allow an advantage to persist against competition and substitution.
Capital Architecture
How capital enters the company, where it is deployed, and how operating performance converts into value.
Kill Conditions
The evidence that would materially weaken, invalidate, defer, or reprice the thesis.
From evidence to monitorable structure.
SCI does not compress diligence into a single score. It builds a dependency chain showing what the investment thesis depends upon.
Don't wait for the investment committee to find the weakness.
SCI turns your existing evidence into a structured assessment of what is proven, what remains conditional, what constrains value creation, and what evidence could change the investment outcome.
Underwrite the deal.
Use SCI as an independent structural review before committing capital to a company, round, acquisition, or strategic investment.
- ✓ Structural investment thesis
- ✓ Evidence and uncertainty map
- ✓ Binding constraint identification
- ✓ Structural durability assessment
- ✓ Kill conditions
- ✓ IC-ready decision matrix
- ✓ Post-investment monitoring signals
Stress-test the company before the market does.
Use SCI before fundraising, a major financing round, or institutional diligence to identify the weaknesses an investor is likely to discover.
- ✓ Investment thesis integrity
- ✓ Evidence gap analysis
- ✓ Structural weakness identification
- ✓ Likely investor objections
- ✓ Valuation vulnerability analysis
- ✓ Next-proof requirements
- ✓ Investor-readiness assessment
Six structural domains.
SCI evaluates the conditions that determine whether early company utility can become durable enterprise value.
Market Opportunity
Is demand structurally expanding, and does the company possess a credible wedge into durable demand?
Product Utility
Does the product create measurable leverage, or does value depend on services, intervention, or heroics?
Execution Quality
Can the organization repeatedly build, sell, deploy, and deliver without excessive founder dependency?
Structural Hardness
Are switching costs, workflow dependency, institutional embedding, proprietary assets, or other durable barriers emerging?
Economic Durability
Does value capture remain aligned with value creation as the company scales?
Governance Maturity
Can the company be governed, measured, and monitored under institutional capital?
SCI does not manufacture certainty.
Evidence quality is separated from interpretation so that unknowns remain visible instead of being converted into artificial confidence.
Supported by direct artifacts such as contracts, financial statements, product telemetry, customer evidence, filings, or other supplied documentation.
Patterns supported by available evidence but requiring additional validation before being treated as structural fact.
Unknowns that materially affect the thesis and therefore become explicit diligence requirements or monitoring conditions.
An unknown is not treated as a negative. It is treated as a condition that must be resolved.
See the underwriting structure.
Ratings are evidence-weighted. Confidence reflects the quality and completeness of the underlying evidence—not narrative confidence.
| Dimension | Rating | Structural Finding | Confidence |
|---|---|---|---|
| Market Opportunity | 7 / 10 |
[Verified] Clear ICP and documented pain. [Observed] Fragmented competitive environment. [Uncertainty] Market size and category dominance remain unvalidated. |
Moderate |
| Product Utility | 8 / 10 |
[Verified] Measurable workflow improvement in pilot evidence. [Observed] Repeated daily workflow usage. [Uncertainty] Peak-load durability not demonstrated. |
Moderate |
| Execution Quality | 6 / 10 |
[Verified] Active production delivery. [Observed] Significant sales-cycle dispersion. [Uncertainty] Retention and expansion cohorts incomplete. |
Limited–Moderate |
| Structural Hardness | 5 / 10 |
[Observed] Switching costs emerging but not yet locked. [Inference] Workflow-hub potential exists. [Uncertainty] Proprietary data advantage not established. |
Limited |
| Economic Durability | 6 / 10 |
[Verified] Strong reported gross margin. [Observed] Pricing power remains untested. [Uncertainty] CAC payback and retention durability incomplete. |
Limited–Moderate |
| Governance Maturity | 4 / 10 |
[Verified] Basic governance infrastructure exists. [Observed] KPI definitions remain inconsistent. [Uncertainty] Formal institutional risk controls incomplete. |
Limited |
| Overall Structural Assessment | 6.0 / 10 | Utility is established. Execution is active. The underwriting hinge is whether early product value becomes durable structural dependency and repeatable economics. | Moderate |
One structure across the investment lifecycle.
SCI is designed to remain useful after the initial investment decision.
Before Capital
Convert company claims into evidence requirements and structural underwriting questions.
- Evidence intake + gap map
- Structural thesis
- Binding constraints
- Kill conditions
Investment Committee
Make the decision legible: what is proven, what remains conditional, and what changes the outcome.
- IC-ready decision matrix
- Capital architecture
- Recommendation posture
- Next validation event
After Capital
Monitor structural progress instead of relying exclusively on vanity metrics.
- Primary monitoring signals
- Catalyst tracking
- Constraint burn-down
- Thesis deterioration alerts
See what SCI actually does.
C3.ai — Public Evidence Assessment
A public-data demonstration showing how SCI separates market narrative from structural evidence, identifies the underwriting hinge, and converts uncertainty into explicit validation requirements.
Conventional Market Narrative
Enterprise AI exposure, subscription-dominant revenue, significant liquidity, and participation in a rapidly expanding technology category.
SCI Structural Underwriting
Posture: Additional Due Diligence Required. The structural question is not simply whether demand exists, but whether the company can convert demand into durable economics, operating leverage, and defensible customer dependency.
Executive Structural Scorecard
Explore the complete institutional assessment.
Review the evidence classifications, structural findings, decision matrix, and kill-condition framework applied to public market evidence.
Built for decisions where capital is at risk.
SCI can operate as an independent underwriting layer alongside existing investment teams, advisors, analysts, and internal tools.
Investment Committees
Make the conditions behind an investment thesis explicit and reviewable.
Family Offices
Add independent structural analysis to concentrated or high-conviction decisions.
Venture Funds
Standardize evidence quality across deals without replacing existing investment judgment.
Strategic Investors
Examine operational dependencies and structural fit before committing capital or resources.
Corporate Development
Surface structural dependencies, integration risks, and value-conversion constraints.
Independent Review
Obtain a structured second opinion when the decision requires evidence beyond the internal narrative.
Prepare before the market underwrites you.
SCI can also be deployed from the company side to identify the structural weaknesses an institutional investor is likely to discover.
SCI Structural Readiness Assessment
Before entering a major financing process, companies can use the same evidence discipline to identify missing proof, structural dependencies, valuation vulnerabilities, and likely investment committee objections.
Turn a live investment decision into a structured underwriting object.
An independent structural assessment for investors who need to know what must be true before capital is committed—and what evidence would indicate that the thesis is weakening after deployment.
You provide the evidence.
Give SCI the materials already available to the investment team. The objective is not to create more information. It is to determine what the existing evidence actually establishes.
- Pitch deck and company materials
- Financial information and operating metrics
- Customer and product evidence
- Contracts and commercial documentation
- Existing diligence and research
- Other available company evidence
SCI returns the structure.
- Structural Investment Thesis
- Evidence Registry + Gap Map
- Binding Constraint
- Structural Catalysts
- Capital Architecture
- Kill Conditions
- Decision Matrix
- IC-Ready Memorandum
- Monitoring Signals
Designed for decisions where the cost of missing a structural weakness is materially greater than the cost of finding it before capital is deployed.
Have a live investment decision?
Don't give SCI a pitch. Give it the evidence.
Provide the company materials, financial information, operating evidence, customer data, product information, and other available artifacts. SCI structures the thesis, identifies the binding constraints, exposes the unknowns, defines kill conditions, and returns an IC-ready assessment.
Typical SCI engagement output
One live decision. One independent structural assessment.
SCI is designed for situations where the cost of being structurally wrong is greater than the cost of obtaining another opinion.
SCI provides structured investment intelligence and does not replace legal, accounting, financial, or investment advice.
Evidence → Structure → Underwriting → Decision → Monitoring
Independent structural underwriting infrastructure for decisions where capital is at risk.